GORI SAVELLINI GIANNI

Gianni
Gori Savellini
Ricercatore Legge 240/10 - tempo determinato

Office hours

  • Tuesday from 09:00 to 10:00
    Place: Dipartimento di Biotecnologie Mediche, Policlinico Le Scotte, 5° lotto 2° piano, c/o UOC Microbiologia e Virologia.

Contacts

0577/935494

Curriculum Vitae

Teaching activities

Completion accademic year: 2024/2025

Completion accademic year: 2023/2024

Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2023/2024

Completion accademic year: 2022/2023

Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2022/2023

Completion accademic year: 2021/2022

Research

Ultime pubblicazioni:

  • Gori Savellini, G., Anichini, G., Manetti, F., Trivisani, C.I., Cusi, M.G. (2024). Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication. VIRUSES, 16(5) [10.3390/v16050689]. - view more
  • De Angelis, M., Anichini, G., Palamara, A.T., Nencioni, L., Gori Savellini, G. (2023). Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein. VIROLOGY JOURNAL, 20(1) [10.1186/s12985-023-02208-7]. - view more
  • Gori Savellini, G., Anichini, G., Cusi, M.G. (2023). SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells. VIRUS RESEARCH, 332 [10.1016/j.virusres.2023.199134]. - view more
  • Cusi, M.G., Di Giacomo, A.M., Anichini, G., Gori Savellini, G., Terrosi, C., Gandolfo, C., et al. (2023). Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID. VIRUSES, 15(3), 614 [10.3390/v15030614]. - view more
  • Anichini, G., Terrosi, C., Gori Savellini, G., Gandolfo, C., Barbagli, F., Carta, G.A., et al. (2022). Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine. VACCINES, 10(9) [10.3390/vaccines10091512]. - view more